Anti-osteoporotic drug release from ordered mesoporous bioceramics: Experiments and modeling

AAPS PharmSciTech

Volumn 12, Issue 4, 2011, Pages 1193-1199

  Manzano, Miguel ^a,b   Lamberti, Gaetano ^c   Galdi, Ivan ^c   Vallet Regí, María ^a,b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^c UNIVERSITY OF SALERNO   (Italy)

Author keywords

drug delivery; modeling; ordered mesoporous matrices

Indexed keywords

BIOCERAMICS; BISPHOSPHONIC ACID DERIVATIVE; ZOLEDRONIC ACID;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG STRUCTURE; EXPERIMENTAL STUDY; ISOTHERM; PREDICTION; PRIORITY JOURNAL; X RAY DIFFRACTION;

BONE DENSITY CONSERVATION AGENTS; CERAMICS; CHEMISTRY, PHARMACEUTICAL; DIPHOSPHONATES; DRUG CARRIERS; DRUG COMPOUNDING; IMIDAZOLES; KINETICS; MODELS, CHEMICAL; REPRODUCIBILITY OF RESULTS; SILICON DIOXIDE; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL;

EID: 83555168294     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-011-9688-9     Document Type: Article

References (30)

1. M Manzano M Colilla M Vallet-Regí 2009 Drug delivery from ordered mesoporous matrices Expert Opin Drug Delivery 6 12 1383 400 10.1517/ 17425240903304024 1:CAS:528:DC%2BD1MXhs1aqtb7N
2. I Izquierdo-Barba L Ruiz-González JC Doadrio JM González-Calbet M Vallet-Regí 2005 Tissue regeneration: a new property of mesoporous materials Solid State Sci 7 8 983 9 10.1016/j. solidstatesciences.2005.04.003 1:CAS:528:DC%2BD2MXms1ymtLs%3D (Pubitemid 41068445)
3. M Vallet Regí 2006 Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering Chem Eur J 12 23 5934 43 16832799 10.1002/chem.200600226 (Pubitemid 44231020)
4. M Vallet Regí 2010 Nanostructured mesoporous silica matrices in nanomedicine J Intern Med 267 1 22 43 20059642 10.1111/j.1365-2796.2009.02190.x
5. M Manzano M Vallet-Regí 2010 New developments in ordered mesoporous materials for drug delivery J. Mater. Chem. 20 27 5593 604 10.1039/b922651f 1:CAS:528:DC%2BC3cXotVSrtLY%3D
6. M Colilla M Manzano M Vallet-Regí 2008 Recent advances in ceramic implants as drug delivery systems for biomedical applications Int J Nanomed 3 4 403 1:CAS:528:DC%2BD1MXjtFGiurY%3D
7. LL Hench J Wilson 1984 Surface-active biomaterials Science 226 630 6 6093253 10.1126/science.6093253 1:CAS:528:DyaL2MXht1ahtQ%3D%3D (Pubitemid 15202145)
8. MA Vallet-Regi L Ruiz-Gonzalez I Izquierdo-Barba JM Gonzalez-Calbet 2006 Revisiting silica based ordered mesoporous materials: medical applications J. Mater. Chem. 16 1 26 31 10.1039/b509744d 10.1039/b509744d 1:CAS:528: DC%2BD2MXhtlShtr%2FK (Pubitemid 43324482)
9. GA Rodan TJ Martin 2000 Therapeutic approaches to bone diseases Science 289 5484 1508 10968781 10.1126/science.289.5484.1508 1:CAS:528: DC%2BD3cXmt1Kgsb4%3D
10. R Russell M Rogers 1999 Bisphosphonates: from the laboratory to the clinic and back again Bone 25 1 97 106 10423031 10.1016/S8756-3282(99)00116-7 1:CAS:528:DyaK1MXkvV2ru70%3D (Pubitemid 29322070)
11. G Nancollas R Tang R Phipps Z Henneman S Gulde W Wu, et al. 2006 Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite Bone 38 5 617 27 16046206 10.1016/j.bone.2005.05.003 1:CAS:528:DC%2BD28XjvFSjtr4%3D
12. S Woo J Hellstein J Kalmar 2006 Narrative (corrected) review: bisphosphonates and osteonecrosis of the jaws (published correction appears in Ann Intern Med 2006; 145 [3]: 235) Ann Intern Med. 144 10 753 61 16702591 1:CAS:528:DC%2BD28XlsFKhs70%3D
13. EH Nafea MA El-Massik LK El-Khordagui M Marei NM Khalafallah 2007 Alendronate PLGA microspheres with high loading efficiency for dental applications J Microencapsulation. 24 6 525 38 17654173 10.1080/ 02652040701439807 1:CAS:528:DC%2BD2sXotVOjtLY%3D (Pubitemid 47180536)
14. JS Baek HH Kwon JS Hwang HC Sung JM Lee SC Shin, et al. 2011 Alendronate-loaded microparticles for improvement of intestinal cellular absorption J Drug Target. 19 1 37 48 10.3109/10611861003667599 20477555 10.3109/10611861003667599 1:CAS:528:DC%2BC3cXhsFamtb3O
15. X Shi Y Wang L Ren Y Gong DA Wang 2009 Enhancing alendronate release from a novel PLGA/hydroxyapatite microspheric system for bone repairing applications Pharm. Res. 26 2 422 30 18979188 10.1007/s11095-008-9759-0 1:CAS:528: DC%2BD1cXhtlWhtbvF
16. S Josse C Faucheux A Soueidan G Grimandi D Massiot B Alonso, et al. 2005 Novel biomaterials for bisphosphonate delivery Biomaterials 26 14 2073 80 15576181 10.1016/j.biomaterials.2004.05.019 1:CAS:528:DC%2BD2cXhtVCiurfL (Pubitemid 39575349)
17. B Peter O Gauthier S Laib B Bujoli J Guicheux P Janvier, et al. 2006 Local delivery of bisphosphonate from coated orthopedic implants increases implants mechanical stability in osteoporotic rats J Biomed Mater Res Part A. 76A 1 133 43 10.1002/jbm.a.30456 10.1002/jbm.a.30456 1:CAS:528: DC%2BD28XhsVehug%3D%3D (Pubitemid 43075691)
18. F Balas M Manzano P Horcajada M Vallet-Regí 2006 Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials J. Am. Chem. Soc. 128 25 8116 7 16787058 10.1021/ja062286z 1:CAS:528:DC%2BD28XltlSntb4%3D (Pubitemid 43967738)
19. A Nieto F Balas M Colilla M Manzano M Vallet-Regí 2008 Functionalization degree of SBA-15 as key factor to modulate sodium alendronate dosage Microporous Mesoporous Mater. 116 1-3 4 13 10.1016/j.micromeso.2008.03. 025 1:CAS:528:DC%2BD1cXhtlSmtrrJ
20. M Colilla M Manzano I Izquierdo-Barba M Vallet-Regi C Boissiere C Sanchez 2010 Advanced drug delivery vectors with tailored surface properties made of mesoporous binary oxides submicronic spheres Chem. Mater. 22 5 1821 30 10.1021/cm9033484 10.1021/cm9033484 1:CAS:528:DC%2BC3cXjtFyj
21. M Colilla I Izquierdo-Barba M Vallet-Regi 2010 Phosphorus-containing SBA-15 materials as bisphosphonate carriers for osteoporosis treatment Microporous Mesoporous Mater. 135 1-3 51 9 10.1016/j.micromeso.2010.06.010 1:CAS:528:DC%2BC3cXhtVKjurvJ
22. S Chirico A Dalmoro G Lamberti G Russo G Titomanlio 2007 Analysis and modeling of swelling and erosion behavior for pure HPMC tablet J Controlled Release 122 2 181 8 DOI 10.1016/j.jconrel.2007.07.001 10.1016/j.jconrel.2007.07. 001 1:CAS:528:DC%2BD2sXhtVSktbnF (Pubitemid 47361406)
23. DY Zhao JL Feng QS Huo N Melosh GH Fredrickson BF Chmelka, et al. 1998 Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores Science 279 5350 548 52 9438845 10.1126/science.279.5350.548 1:CAS:528:DyaK1cXotVOitQ%3D%3D (Pubitemid 28067280)
24. Lapidus L, Pinder GF. Numerical solution of partial differential equations in science and engineering. New York: Wiley-Interscience; 1982.
25. COMSOL. Multiphysics User's Guide: Comsol AB; 1994-2007.
26. Galdi I, Lamberti G. Drug release from matrix systems. Analysis by finite element methods heat and mass transfer. 2011. doi: 10.1007/s00231-011-0900-y.
27. Sing K, Gregg S. Adsorption, surface area and porosity. London: Academic Press; 1982.
28. M Vallet-Regi M Manzano JM Gonzalez-Calbet E Okunishi 2010 Evidence of drug confinement into silica mesoporous matrices by STEM spherical aberration corrected microscopy Chem. Commun. 46 17 2956 8 10.1039/c000806k 10.1039/c000806k 1:CAS:528:DC%2BC3cXksFOrsrc%3D
29. M Di Muria G Lamberti G Titomanlio 2009 Modeling the pharmacokinetics of extended release pharmaceutical systems Heat Mass Transfer 45 5 579 89 10.1007/s00231-008-0456-7 10.1007/s00231-008-0456-7
30. M Di Muria G Lamberti G Titomanlio 2010 Physiologically based pharmacokinetics: a simple, all purpose model Ind. Eng. Chem. Res. 49 6 2969 78 10.1021/ie9015717